178 related articles for article (PubMed ID: 34474553)
21. MicroRNA-185 inhibits proliferation, migration and invasion in human osteosarcoma MG63 cells by targeting vesicle-associated membrane protein 2.
Li L; Wang X; Liu D
Gene; 2019 May; 696():80-87. PubMed ID: 30721745
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential.
Sun R; Shen J; Gao Y; Zhou Y; Yu Z; Hornicek F; Kan Q; Duan Z
Oncotarget; 2016 Jun; 7(25):38333-38346. PubMed ID: 27223261
[TBL] [Abstract][Full Text] [Related]
24. Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E.
Qi NN; Tian S; Li X; Wang FL; Liu B
Biochimie; 2019 Aug; 163():1-11. PubMed ID: 30998968
[TBL] [Abstract][Full Text] [Related]
25. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
26. DDX10 overexpression predicts worse prognosis in osteosarcoma and its deletion prohibits cell activities modulated by MAPK pathway.
Shi JH; Hao YJ
Biochem Biophys Res Commun; 2019 Mar; 510(4):525-529. PubMed ID: 30738579
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of ecotropic viral integration site 2A indicates a poor prognosis and promotes osteosarcoma evolution through activating MEK/ERK pathway.
Li S; Yang F; Yang YK; Zhou Y
J Recept Signal Transduct Res; 2019 Aug; 39(4):368-372. PubMed ID: 31774019
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of HCG18 Inhibits Cell Viability, Migration and Invasion in Pediatric Osteosarcoma by Targeting miR-188-5p/FOXC1 Axis.
Zhao Z; Chen J; Xia D
Mol Biotechnol; 2021 Sep; 63(9):807-817. PubMed ID: 34041718
[TBL] [Abstract][Full Text] [Related]
29. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-99b predicts clinical outcome of osteosarcoma and suppresses tumor cell proliferation, migration and invasion.
Shi X; Guan X
Diagn Pathol; 2019 Oct; 14(1):117. PubMed ID: 31651329
[TBL] [Abstract][Full Text] [Related]
31. miR-487b and TRAK2 that form an axis to regulate the aggressiveness of osteosarcoma, are potential therapeutic targets and prognostic biomarkers.
Wang F; Ye BG; Liu JZ; Kong DL
J Biochem Mol Toxicol; 2020 Aug; 34(8):e22511. PubMed ID: 32267991
[TBL] [Abstract][Full Text] [Related]
32. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract][Full Text] [Related]
33. Interfering with pak4 Protein Expression Affects Osteosarcoma Cell Proliferation and Migration.
Fu Y; Fang L; Yin Q; Wu Q; Sui W; Sun Y; Zhao X; Wu Y; Zhou L
Biomed Res Int; 2021; 2021():9977001. PubMed ID: 35005025
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
35. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
36. Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP-1 signaling pathway.
Han Y; Zhao X; Sun Y; Sui Y; Liu J
J Cell Physiol; 2019 Apr; 234(4):3598-3612. PubMed ID: 30471098
[TBL] [Abstract][Full Text] [Related]
37. circUBAP2 regulates osteosarcoma progression via the miR‑204‑3p/HMGA2 axis.
Ma W; Xue N; Zhang J; Wang D; Yao X; Lin L; Xu Q
Int J Oncol; 2021 Mar; 58(3):298-311. PubMed ID: 33650644
[TBL] [Abstract][Full Text] [Related]
38. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis and validation of mesenchymal stem cells related gene MT1G in osteosarcoma.
Zheng S; Cheng X; Ke S; Zhang L; Wu H; He D; Cheng X
Aging (Albany NY); 2024 May; 16(9):8155-8170. PubMed ID: 38747739
[TBL] [Abstract][Full Text] [Related]
40. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
